首页 › 重度抑郁症 › 得克萨斯州 › Wichita Falls
Wichita Falls TX 重度抑郁症临床试验
6项针对 重度抑郁症的研究正在 Wichita Falls及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- Grayline Research Center, Wichita Falls
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Wichita Falls
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
招募中2 期
- Grayline Research Center, Wichita Falls
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Grayline Research Center, Wichita Falls
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Wichita Falls
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
招募中4 期
- Clinical Research Site, Wichita Falls
其他城市的 重度抑郁症试验
- New York City, NY36 项研究
- Boston, MA31 项研究
- Atlanta, GA25 项研究
- Philadelphia, PA23 项研究
- Orlando, FL19 项研究
- Miami, FL18 项研究
- Chicago, IL17 项研究
- Tampa, FL17 项研究
- Houston, TX16 项研究
- San Diego, CA16 项研究
- Little Rock, AR14 项研究
- Austin, TX13 项研究
Wichita Falls的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。